Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.

Eli Lilly finally has FDA approval for its amyloid-busting Alzheimer’s disease therapy donanemab and will launch it at a cost it claims could deliver savings compared to a rival therapy from ...

Adrià Calatayud is deputy breaking news editor for the EMEA desk at Dow Jones Newswires in Barcelona. Adrià covers European telecommunications, media and logistics companies. He was previously a ...

The discovery of a contaminant in batches of heparin throws into stark relief the difficulties, not only for the US Food and Drug Administration, but also for international regulatory agencies, to ...

Canada’s Prime Minister (PM) Mark Carney has often vociferously and unequivocally voiced Canada’s support for Ukraine in their war with Russia: “Canada’s support for Ukraine is unwavering”; “We are ...